- Home
- BWEN vs LGVN Comparison
BWEN vs LGVN Comparison
Compare BWEN & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- LGVN
- Stock Information
- Founded
- BWEN N/A
- LGVN 2014
- Country
- BWEN United States
- LGVN United States
- Employees
- BWEN N/A
- LGVN N/A
- Industry
- BWEN Industrial Machinery/Components
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- BWEN Industrials
- LGVN Health Care
- Exchange
- BWEN Nasdaq
- LGVN Nasdaq
- Market Cap
- BWEN 33.7M
- LGVN 23.4M
- IPO Year
- BWEN N/A
- LGVN 2021
- Fundamental
- Price
- BWEN $1.61
- LGVN $1.47
- Analyst Decision
- BWEN Strong Buy
- LGVN Strong Buy
- Analyst Count
- BWEN 3
- LGVN 3
- Target Price
- BWEN $4.50
- LGVN $8.67
- AVG Volume (30 Days)
- BWEN 70.8K
- LGVN 121.7K
- Earning Date
- BWEN 05-13-2025
- LGVN 05-08-2025
- Dividend Yield
- BWEN N/A
- LGVN N/A
- EPS Growth
- BWEN N/A
- LGVN N/A
- EPS
- BWEN 0.05
- LGVN N/A
- Revenue
- BWEN $143,136,000.00
- LGVN $2,225,000.00
- Revenue This Year
- BWEN $8.78
- LGVN $1.30
- Revenue Next Year
- BWEN $10.05
- LGVN $19.15
- P/E Ratio
- BWEN $32.20
- LGVN N/A
- Revenue Growth
- BWEN N/A
- LGVN 127.50
- 52 Week Low
- BWEN $1.41
- LGVN $0.77
- 52 Week High
- BWEN $4.65
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- BWEN 55.58
- LGVN 46.88
- Support Level
- BWEN $1.58
- LGVN $1.30
- Resistance Level
- BWEN $1.72
- LGVN $1.77
- Average True Range (ATR)
- BWEN 0.07
- LGVN 0.12
- MACD
- BWEN 0.01
- LGVN -0.02
- Stochastic Oscillator
- BWEN 52.17
- LGVN 32.08
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.